Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period

Lotte Sahin Levison,1 Reimar Wernich Thomsen,2 Diana Hedevang Christensen,2 Thomas Mellemkjær,1 Søren Hein Sindrup,3 Henning Andersen11Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus,...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Levison LS, Thomsen RW, Christensen DH, Mellemkjær T, Sindrup SH, Andersen H
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: Dove Medical Press 2019-04-01
মালা:Clinical Epidemiology
বিষয়গুলি:
অনলাইন ব্যবহার করুন:https://www.dovepress.com/guillain-barre-syndrome-in-denmark-validation-of-diagnostic-codes-and--peer-reviewed-article-CLEP
_version_ 1828485994489315328
author Levison LS
Thomsen RW
Christensen DH
Mellemkjær T
Sindrup SH
Andersen H
author_facet Levison LS
Thomsen RW
Christensen DH
Mellemkjær T
Sindrup SH
Andersen H
author_sort Levison LS
collection DOAJ
description Lotte Sahin Levison,1 Reimar Wernich Thomsen,2 Diana Hedevang Christensen,2 Thomas Mellemkjær,1 Søren Hein Sindrup,3 Henning Andersen11Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Neurology, Odense University Hospital, Odense, DenmarkPurpose: To validate the diagnostic codes for Guillain-Barré syndrome (GBS) in the Danish National Patient Registry (DNPR). Secondly, to examine 30-year trends in the incidence of GBS in Denmark.Patients and methods: We used the DNPR to identify all patients aged 16 and above diagnosed with a primary GBS diagnosis at any Danish department of neurology between 1987 and 2016. Medical files were reviewed according to the clinical criteria of the National Institute of Neurological Disorders and Stroke Committee and classified according to the Brighton criteria. The incidence rate (IR) was calculated based on data from 1987 to 2016 and stratified by season, gender, and age.Results: Over 30 years, we identified 2,319 patients aged 16 and above in the DNPR. From a validation cohort of 573 patients, we were able to retrieve 425 (74.2%) medical files; 356 GBS diagnoses were confirmed. The overall positive predictive value was 83.8% (95% confidence interval (CI): 80.0–87.0). In 99% of the confirmed patients, the Brighton criteria level 1–3 for GBS were met. The IR was fairly stable over 30 years at 1.77 per 100,000 person years (95% CI: 1.70–1.84). The incidence was higher in the winter season (IR ratio compared with summer: 1.18 (95% CI: 1.09–1.29)), and was strongly associated with male gender (IR ratio vs females: 1.44 (95% CI: 1.33–1.57)). IRs rose with age at diagnosis, particularly after the age of 50 in both men and women and a minor peak was observed for total IR in young adults.Conclusion: Primary diagnostic codes for GBS at Danish departments of neurology have high validity. The DNPR is a well-suited data source for epidemiological research on GBS. The Danish nationwide 30-year GBS IR is stable over time and similar to GBS IRs reported in other European and North American populations.Keywords: registries, positive predictive value, international classification of disease codes, epidemiology
first_indexed 2024-12-11T09:23:50Z
format Article
id doaj.art-89e20f7ab29545299352f23ad9dceb58
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-12-11T09:23:50Z
publishDate 2019-04-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-89e20f7ab29545299352f23ad9dceb582022-12-22T01:13:11ZengDove Medical PressClinical Epidemiology1179-13492019-04-01Volume 1127528345228Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year periodLevison LSThomsen RWChristensen DHMellemkjær TSindrup SHAndersen HLotte Sahin Levison,1 Reimar Wernich Thomsen,2 Diana Hedevang Christensen,2 Thomas Mellemkjær,1 Søren Hein Sindrup,3 Henning Andersen11Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Neurology, Odense University Hospital, Odense, DenmarkPurpose: To validate the diagnostic codes for Guillain-Barré syndrome (GBS) in the Danish National Patient Registry (DNPR). Secondly, to examine 30-year trends in the incidence of GBS in Denmark.Patients and methods: We used the DNPR to identify all patients aged 16 and above diagnosed with a primary GBS diagnosis at any Danish department of neurology between 1987 and 2016. Medical files were reviewed according to the clinical criteria of the National Institute of Neurological Disorders and Stroke Committee and classified according to the Brighton criteria. The incidence rate (IR) was calculated based on data from 1987 to 2016 and stratified by season, gender, and age.Results: Over 30 years, we identified 2,319 patients aged 16 and above in the DNPR. From a validation cohort of 573 patients, we were able to retrieve 425 (74.2%) medical files; 356 GBS diagnoses were confirmed. The overall positive predictive value was 83.8% (95% confidence interval (CI): 80.0–87.0). In 99% of the confirmed patients, the Brighton criteria level 1–3 for GBS were met. The IR was fairly stable over 30 years at 1.77 per 100,000 person years (95% CI: 1.70–1.84). The incidence was higher in the winter season (IR ratio compared with summer: 1.18 (95% CI: 1.09–1.29)), and was strongly associated with male gender (IR ratio vs females: 1.44 (95% CI: 1.33–1.57)). IRs rose with age at diagnosis, particularly after the age of 50 in both men and women and a minor peak was observed for total IR in young adults.Conclusion: Primary diagnostic codes for GBS at Danish departments of neurology have high validity. The DNPR is a well-suited data source for epidemiological research on GBS. The Danish nationwide 30-year GBS IR is stable over time and similar to GBS IRs reported in other European and North American populations.Keywords: registries, positive predictive value, international classification of disease codes, epidemiologyhttps://www.dovepress.com/guillain-barre-syndrome-in-denmark-validation-of-diagnostic-codes-and--peer-reviewed-article-CLEPRegistriespositive predictive valueInternational Classification of Disease codesepidemiology
spellingShingle Levison LS
Thomsen RW
Christensen DH
Mellemkjær T
Sindrup SH
Andersen H
Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
Clinical Epidemiology
Registries
positive predictive value
International Classification of Disease codes
epidemiology
title Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
title_full Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
title_fullStr Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
title_full_unstemmed Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
title_short Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
title_sort guillain barr eacute syndrome in denmark validation of diagnostic codes and a population based nationwide study of the incidence in a 30 year period
topic Registries
positive predictive value
International Classification of Disease codes
epidemiology
url https://www.dovepress.com/guillain-barre-syndrome-in-denmark-validation-of-diagnostic-codes-and--peer-reviewed-article-CLEP
work_keys_str_mv AT levisonls guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod
AT thomsenrw guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod
AT christensendh guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod
AT mellemkjært guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod
AT sindrupsh guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod
AT andersenh guillainbarreacutesyndromeindenmarkvalidationofdiagnosticcodesandapopulationbasednationwidestudyoftheincidenceina30yearperiod